| QA2022109 | Atorvastatin Impurity 109
CAS# 1817798-20-1
M.F.: C26H24FNO3
M.W.: 417.48 |
|  |
| QA2022108 | Atorvastatin Impurity 108
CAS# 62148-67-8
M.F.: C14H10ClFO
M.W.: 248.68 |
| |
| QA2022107 | Atorvastatin Impurity 107
CAS# NA
M.F.: C33H33FN2O6
M.W.: 572.63 |
| |
| QA2022106 | Atorvastatin Impurity 106
CAS# NA
M.F.: C11H23NO4
M.W.: 233.30 |
| |
| QA2022105 | Atorvastatin Impurity 105
CAS# NA
M.F.: C10H19NO4
M.W.: 217.26 |
| |
| QA2022104 | Atorvastatin Impurity 104
CAS# NA
M.F.: C7H11NO4
M.W.: 173.17 |
| |
| QA2022103 | Atorvastatin Impurity 103
CAS# 807312-27-2
M.F.: C10H15NO4
M.W.: 213.23 |
| |
| QA2022102 | Atorvastatin Impurity 102
CAS# NA
M.F.: C31H48N2O8
M.W.: 576.72 |
| |
| QA2022101 | Atorvastatin Impurity 101
CAS# NA
M.F.: C28H29NO3
M.W.: 427.53 |
| |
| QA2022100 | Atorvastatin Impurity 100
CAS# 88675-31-4
M.F.: C14H10BrFO
M.W.: 293.13 |
| |
| QA202299 | Atorvastatin Impurity 99
CAS# 134394-98-2
M.F.: C37H41FN2O5
M.W.: 612.73 |
| |
| QA202298 | Atorvastatin EP Impurity J
CAS# NA
M.F.: C33H33FN2O4
M.W.: 540.62 |
| |
| QA202297 | Atorvastatin 3-Deoxyhept-2Z-Enoic Acid Sodium Salt
CAS# 1659317-56-2;1191901-60-6(free base)
M.F.: C33H32FN2NaO4
M.W.: 562.61 |
| |
| QA202296 | Atorvastatin Impurity 96
CAS# 125988-01-4
M.F.: C11H17NO4
M.W.: 227.26 |
| |
| QA202295 | Atorvastatin Impurity 95
CAS# 791553-16-7(free base);131275-93-9(Na salt)
M.F.: C66H68CaF2N4O10
M.W.: 1155.34 |
| |
| QA202294 | Atorvastatin Impurity 94
CAS# 887470-43-1(free base)
M.F.: C33H34FN2O7 1/2 Ca
M.W.: 589.63 20.04 |
| |
| QA202293 | Atorvastatin Impurity 93
CAS# 186508-95-2
M.F.: C14H23NO4
M.W.: 269.34 |
| |
| QA202292 | 2-Hydroxy Atorvastatin Lactone-d5
CAS# 265989-50-2
M.F.: C33H28D5FN2O5
M.W.: 561.65 |
| |
| QA202291 | Atorvastatin Impurity 91
CAS# NA
M.F.: C33H35FN2O7
M.W.: 590.64 |
| |
| QA202290 | Atorvastatin oxirane
CAS# 1246818-88-1
M.F.: C26H24FNO3
M.W.: 417.47 |
| |
| QA202289 | Atorvastatin Impurity 89
CAS# NA
M.F.: C39H39FN2O5
M.W.: 634.74 |
| |
| QA202288 | Atorvastatin Impurity 88
CAS# 2243639-97-4
M.F.: C33H35FN2O5
M.W.: 558.64 |
| |
| QA202287 | Atorvastatin Impurity 87
CAS# 1797905-42-0
M.F.: C26H24FNO3
M.W.: 417.47 |
| |
| QA202286 | Atorvastatin Impurity 86
CAS# NA
M.F.: C28H51NO8
M.W.: 529.71 |
| |
| QA202285 | Atorvastatin Impurity 85
CAS# 2299304-89-3
M.F.: C24H44N2O7
M.W.: 472.62 |
| |
| QA202284 | ortho-Hydroxy Atorvastatin-d5 Calcium Salt
CAS# 265989-47-7
M.F.: C66H58D10CaF2N4O12
M.W.: 1197.40 |
| |
| QA202283 | Atorvastatin-d5 Calcium Salt
CAS# 222412-82-0
M.F.: C66H58D10CaF2N4O10
M.W.: 1165.40 |
| |
| QA202282 | para-Hydroxy Atorvastatin-d5 Calcium Salt
CAS# 265989-45-5
M.F.: C66H58D10CaF2N4O12
M.W.: 1197.40 |
| |
| QA202281 | Atorvastatin Impurity 81
CAS# NA
M.F.: C80H94CaF2N6O16
M.W.: 1473.71 |
| |
| QA202279 | Atorvastatin Impurity 79
CAS# 472967-95-6
M.F.: C40H47FN2O5
M.W.: 654.81 |
| |
| QA202278 | Atorvastatin Impurity 78
CAS# 947249-30-1
M.F.: C40H47FN2O5
M.W.: 654.81 |
| |
| QA202277 | Atorvastatin Impurity 77
CAS# 1105067-90-0
M.F.: C40H47FN2O5
M.W.: 654.81 |
| |
| QA202276 | Atorvastatin Impurity 26
CAS# NA
M.F.: C40H47FN2O5
M.W.: 654.81 |
| |
| QA202275 | Atorvastatin Impurity 25
CAS# NA
M.F.: C33H36FN3O4
M.W.: 557.66 |
| |
| QA202274 | Atorvastatin Impurity 24
CAS# NA
M.F.: C66H60CaF2N4O6
M.W.: 1083.28 |
| |
| QA202273 | Atorvastatin Impurity 23;Atorvastatin EP Impurity O
CAS# 887196-30-7
M.F.: C33H33FN2O5
M.W.: 556.62 |
| |
| QA202272 | Atorvastatin Impurity 22
CAS# NA
M.F.: C52H58CaF2N2O8
M.W.: 917.10 |
| |
| QA202271 | Atorvastatin Impurity 21
CAS# NA
M.F.: C26H24FNO5
M.W.: 449.47 |
| |
| QA202270 | Atorvastatin Impurity 20
CAS# 906552-18-9;1046118-41-5(Ca salt);
148217-40-7(Na salt)
M.F.: C33H35FN2O6
M.W.: 574.64 |
| |
| QA202269 | Atorvastatin Impurity 19
CAS# NA
M.F.: C33H33FN2O6
M.W.: 572.62 |
| |
| QA202268 | Atorvastatin Impurity 18
CAS# NA
M.F.: C33H35FN2O6
M.W.: 574.64 |
| |
| QA202262 | Atorvastatin Impurity 12
CAS# 196085-85-5
M.F.: C14H23NO4
M.W.: 269.34 |
| |
| QA202250 | Atorvastatin Impurity Z
CAS# 196085-84-4
M.F.: C14H23NO4
M.W.: 269.34 |
| |
| QA202267 | Atorvastatin Impurity 17
CAS# 425408-16-8
M.F.: C53H58ClFN4O9
M.W.: 949.50 |
| |
| QA202266 | Atorvastatin Impurity 16
CAS# 1821498-27-4
M.F.: C27H30FNO6
M.W.: 483.53 |
| |
| QA202265 | Atorvastatin Impurity 15
CAS# 887324-53-0;887196-29-4(Ca salt)
M.F.: C34H37FN2O5
M.W.: 572.67 |
| |
| QA202263 | Atorvastatin Impurity 13
CAS# 1316291-19-6 (Na salt);873950-17-5
M.F.: C33H35FN2O7
M.W.: 590.64 |
| |
| QA202261 | Atorvastatin Impurity 11
CAS# NA
M.F.: C44H56FN3O8
M.W.: 773.93 |
| |
| QA202234 | Atorvastatin Impurity O
CAS# NA
M.F.: C37H42F2N2O5
M.W.: 632.74 |
| |
| QA202249 | Atorvastatin Impurity Ⅵ
CAS# NA
M.F.: C37H44N2O5
M.W.: 596.76 |
| |
| QA202248 | Atorvastatin Impurity Ⅴ
CAS# 1116118-82-1
M.F.: C50H64FN3O8
M.W.: 854.06 |
| |
| QA202247 | Atorvastatin Impurity Ⅳ
CAS# 693793-87-2
M.F.: C40H46F2N2O5
M.W.: 672.80 |
| |
| QA202244 | Atorvastatin Impurity Ⅲ
CAS# 1105067-91-1
M.F.: C40H48N2O5
M.W.: 636.82 |
| |
| QA202243 | Atorvastatin Impurity Ⅱ
CAS# 125995-13-3
M.F.: C14H27NO4
M.W.: 273.37 |
| |
| QA202242 | Atorvastatin Impurity Ⅰ
CAS# 125971-96-2
M.F.: C26H24FNO3
M.W.: 417.47 |
| |
| QA202260 | Atorvastatin Impurity 10
CAS# 2088732-01-6
M.F.: C14H27NO4
M.W.: 273.37 |
| |
| QA202259 | Atorvastatin Impurity 9
CAS# 1105067-89-7
M.F.: C14H27NO4
M.W.: 273.37 |
| |
| QA202258 | Atorvastatin Impurity 8
CAS# 947586-93-8
M.F.: C14H27NO4
M.W.: 273.37 |
| |
| QA202257 | Atorvastatin Impurity 7
CAS# 125971-94-0
M.F.: C14H23NO4
M.W.: 269.34 |
| |
| QA202256 | Atorvastatin Impurity 6
CAS# 125971-93-9
M.F.: C11H19NO4
M.W.: 229.27 |
| |
| QA202255 | Atorvastatin Impurity 5
CAS# 693793-82-7
M.F.: C26H23F2NO3
M.W.: 435.46 |
| |
| QA202254 | Atorvastatin Impurity 4
CAS# 444577-70-2
M.F.: C26H25NO3
M.W.: 399.48 |
| |
| QA202253 | Atorvastatin Impurity 3
CAS# 54016-70-5
M.F.: C8H14BrNOS
M.W.: 252.17 |
| |
| QA202252 | Atorvastatin Impurity 2
CAS# 125971-57-5
M.F.: C19H19NO2
M.W.: 293.36 |
| |
| QA202251 | Atorvastatin Impurity 1
CAS# 124401-38-3
M.F.: C12H15NO2
M.W.: 205.25 |
| |
| QA202202 | Atorvastatin EP Impurity B
CAS# NA
M.F.: C33H34FN2O5 . 1/2Ca
M.W.: 577.67 |
| |
| QA202246 | Atorvastatin EP Impurity E;
USP Atorvastatin Related Compound E
CAS# 1105067-88-6
M.F.: C66H68CaF2N4O10
M.W.: 1155.34 |
| |
| QA202241 | Atorvastatin Lactone Diepoxide
CAS# 1046118-40-4
M.F.: C33H33FN2O6
M.W.: 572.62 |
| |
| QA202240 | Atorvastatin Impurity N
CAS# [NA]
M.F.: C33H34FN2O6(Free Base)
M.W.: 573.63(Free Base) |
| |
| QA202239 | Atorvastatin Lactam Lactone
CAS# 906552-19-0
M.F.: C33H33FN2O5
M.W.: 556.62 |
| |
| QA202238 | Atorvastatin Impurity L(Atorvastatin Cyclic Sodium Salt )
CAS# 1316291-19-6
M.F.: C33H34FN2NaO7
M.W.: 612.62 |
| |
| QA202237 | Atorvastatin Impurity K
CAS# 265989-46-6;214217-86-4 (acid);
163217-75-2 (Na);1421760-64-6 (Na, 2H2O);
1581251-44-6 (2Na)
M.F.: C33H34FN2O6.1/2Ca
M.W.: 593.67 |
| |
| QA202236 | Atorvastatin Impurity J
CAS# 265989-44-4
M.F.: C33H34FN2O6.1/2Ca
M.W.: 593.67 |
| |
| QA202235 | Atorvastatin Epoxy Pyrrolooxazin Tricyclic Analog (USP)
CAS# NA
M.F.: C33H33FN2O6
M.W.: 572.62 |
| |
| QA202233 | Atorvastatin FX1 Impurity
CAS# 1315629-79-8
M.F.: C33H34FN2NaO7
M.W.: 612.62 |
| |
| QA202232 | Atorvastatin 4-Hydroxy Lactone
CAS# 163217-70-7
M.F.: C33H33FN2O5
M.W.: 556.62 |
| |
| QA202231 | Atorvastatin 3-Oxo Methyl Ester
CAS# NA
M.F.: C33H35FN2O4
M.W.: 542.64 |
| |
| QA202230 | Atorvastatin 2-Hydroxy Lactone
CAS# 163217-74-1
M.F.: C33H33FN2O5
M.W.: 556.62 |
| |
| QA202229 | Atorvastatin Acetonide Methyl Ester
CAS# 1353049-81-6
M.F.: C37H41FN2O5
M.W.: 612.73 |
| |
| QA202228 | Atorvastatin Lactone 3-O-Methyl Ether
CAS# NA
M.F.: C34H35FN2O4
M.W.: 554.65 |
| |
| QA202227 | Atorvastatin 5-Oxo Acid
CAS# 1391052-82-6
M.F.: C33H33FN2O5
M.W.: 556.62 |
| |
| QA202226 | Atorvastatin 4-Hydroxy Disodium Salt
CAS# 214217-88-6(free base)
M.F.: C33H33FN2Na2O6
M.W.: 618.60 |
| |
| QA202225 | Atorvastatin 3-Oxo Acid Sodium Salt
CAS# 1391052-00-8
M.F.: C33H32FN2NaO5
M.W.: 578.61 |
| |
| QA202224 | Atorvastatin 2-Hydroxy Sodium
CAS# 214217-86-4 (acid);163217-75-2;
265989-46-6 (1/2 Ca);1421760-64-6 (Na, 2H2O);
1581251-44-6 (2N
M.F.: C33H34FN2NaO6
M.W.: 596.62 |
| |
| QA202223 | Atorvastatin (3S,5R)-Isomer Calcium
CAS# 887324-52-9
M.F.: C33H34FN2O5
M.W.: 557.63 |
| |
| QA202222 | Atorvastatin Acetonide;Atorvastatin EP Impurity P
CAS# 581772-29-4
M.F.: C36H39FN2O5
M.W.: 598.7 |
| |
| QA202221 | Atorvastatin Pyrrolidone Analog (USP);
Atorvastatin EP Impurity Q
CAS# 148217-40-7;906552-18-9(free base);
1046118-41-5(Ca salt)
M.F.: C33H34FN2NaO6
M.W.: 596.62 |
| |
| QA202220 | Atorvastatin 5-O-Methyl Sodium
CAS# NA
M.F.: C34H36FN2NaO5
M.W.: 594.65 |
| |
| QA202219 | Atorvastatin Isopropyl Ester
CAS# NA
M.F.: C36H41FN2O5
M.W.: 600.72 |
| |
| QA202218 | Atorvastatin Dehydro Lactone
CAS# 442851-50-5
M.F.: C33H31FN2O3
M.W.: 522.61 |
| |
| QA202217 | Atorvastatin Dehydro Ethyl Ester
CAS# NA
M.F.: C35H37FN2O4
M.W.: 568.68 |
| |
| QA202216 | Atorvastatin t-Butyl Ester;Atorvastatin EP Impurity N
CAS# 134395-00-9
M.F.: C37H43FN2O5
M.W.: 614.75 |
| |
| QA202215 | Atorvastatin Methyl Ester;Atorvastatin EP Impurity K
CAS# 345891-62-5
M.F.: C34H37FN2O5
M.W.: 572.67 |
| |
| QA202214 | Atorvastatin Ethyl Ester;
Atorvastatin EP Impurity M
CAS# 1146977-93-6
M.F.: C35H39FN2O5
M.W.: 586.69 |
| |
| QA202213 | Atorvastatin (3R,5S)-Isomer Sodium Salt
CAS# 131275-93-9; 791553-16-7(free base)
M.F.: C33H34FN2NaO5
M.W.: 580.62 |
| |
| QA202212 | Atorvastatin 3-Deoxy-Hept-2-Enoic Acid (Sodium Salt) (USP)
CAS# 1105067-93-3(free base)
M.F.: C33H32FN2NaO4
M.W.: 562.61 |
| |
| QA202211 | Atorvastatin Epoxy Tetrahydrofuran Analog (USP)
CAS# 873950-19-7
M.F.: C26H24FNO5
M.W.: 449.47 |
| |
| QA202210 | Atorvastatin USP RC B (Calcium Salt)
CAS# 887196-25-0
M.F.: C66H68CaF2N4O10
M.W.: 1155.34 |
| |
| QA202209 | Atorvastatin EP Impurity I;
USP Atorvastatin Related Compound I
CAS# 125971-95-1
M.F.: C40H47FN2O5
M.W.: 654.81 |
| |
| QA202208 | Atorvastatin EP Impurity H;
USP Atorvastatin Related Compound H
CAS# 125995-03-1
M.F.: C33H33FN2O4
M.W.: 540.62 |
| |
| QA202207 | Atorvastatin EP Impurity G
CAS# 887196-29-4;887324-53-0(free base)
M.F.: C34H36FN2O5·1/2Ca
M.W.: 591.74 |
| |
| QA202206 | Atorvastatin EP Impurity F
CAS# 1105067-87-5;1371615-56-3(Na salt)
M.F.: C40H47FN3O8·1/2Ca
M.W.: 736.86 |
| |
| QA202205 | Atorvastatin USP Related Compound E
CAS# 501121-34-2(free base)
M.F.: C33H34FN2NaO5
M.W.: 580.62 |
| |
| QA202204 | Atorvastatin EP Impurity D;
USP Atorvastatin Related Compound D
CAS# 148146-51-4
M.F.: C26H22FNO4
M.W.: 431.46 |
| |
| QA202203 | Atorvastatin EP Impurity C;
USP Atorvastatin Related Compound C
CAS# 693793-53-2(calcium salt)
M.F.: C33H33F2N2NaO5
M.W.: 598.61 |
| |
| QA202201 | Atorvastatin EP Impurity A;
USP Atorvastatin Related Compound A
CAS# 433289-83-9
M.F.: C66H70CaN4O10
M.W.: 1119.36 |
| |
| QA202200NA | Atorvastatin Sodium
CAS# 134523-01-6
M.F.: C33H34FN2NaO5
M.W.: 580.62 |
| |
| QA202200CA | Atorvastatin Calcium Trihydrate
CAS# 344423-98-9;134523-03-8(Ca salt)
M.F.: C66H74CaF2N4O13
M.W.: 1209.39 |
| |
| QA202200 | Atorvastatin
CAS# 134523-00-5
M.F.: C33H35FN2O5
M.W.: 558.64 |
| |
|
